Beth Hecht files SEC Form 4 disclosures for XERIS PHARMACEUTICALS INC. They have made 5 open-market trades across 1 company since 2019, most recently 2026-09-01.
CIK 0001652410
3 open-market purchases totalling $49K since 2019, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XERS | 1,127,796 | $11.7M |
| NEOS | 23,453 | $27K |
| AYTU | 9,052 | $18K |
| ITRM | 18,839 | $593 |
| Total | $11.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XERS | SELL · 10b5-1 | 2026-09-01 | 2026-09-01 | $8.49 | $141K | -11.6% | +7.9% | — |
| XERS | SELL · 10b5-1 | 2026-08-03 | 2026-08-04 | $8.01 | $134K | +4.1% | +4.0% | — |
| XERS | SELL · 10b5-1 | 2026-07-01 | 2026-07-02 | $8.03 | $134K | +4.7% | -2.1% | +15.0% |
| XERS | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $6.06 | $101K | +14.4% | +39.2% | +41.9% |
| XERS | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $6.23 | $104K | +3.0% | -3.0% | +34.7% |
| XERS | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $5.99 | $100K | +2.6% | +5.0% | +36.9% |
| XERS | SELL · 10b5-1 | 2026-03-02 | 2026-03-04 | $6.24 | $104K | -8.8% | +0.5% | -0.4% |
| XERS | SELL | 2026-02-02 | 2026-02-02 | $7.45 | $124K | -6.2% | -17.6% | -14.0% |
| XERS | SELL · 10b5-1 | 2026-01-02 | 2026-01-05 | $7.43 | $124K | +4.5% | -0.1% | -14.7% |
| XERS | SELL · 10b5-1 | 2025-12-01 | 2025-12-02 | $7.01 | $234K | +10.0% | +12.7% | -7.7% |
| XERS | SELL · 10b5-1 | 2025-11-11 | 2025-11-13 | $7.40 | $247K | -0.3% | -1.0% | -2.9% |
| XERS | SELL | 2025-03-20 | 2025-03-21 | $5.43 | $217K | -11.7% | -31.0% | -22.6% |
| XERS | BUY | 2020-03-13 | 2020-03-16 | $1.97 | $8K | +37.3% | +6.0% | +171.7% |
| XERS | BUY | 2020-02-14 | 2020-02-18 | $4.15 | $17K | -21.4% | -62.7% | -8.4% |
| XERS | BUY | 2019-02-19 | 2019-02-22 | $10.00 | $25K | +3.2% | -0.4% | +17.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.